NCT06991231NARecruiting

The Benefits Of Cryoablation In Patients Undergoing Total Knee Arthroplasty

NYU Langone Health

Start Date

6/13/2025

Completion Date

1/1/2027

Summary

The purpose of this study is to evaluate the efficacy of cryoablation use on patient-reported outcomes (PROMs) and opioid consumption following total knee arthroplasty. This is a randomized study that will involve a 1:1 randomization to total knee arthroplasty +/- cryoablation.

Eligibility Criteria

Age Range: 18 years to No maximum

Inclusion Criteria: * Patients are candidates for elective primary total knee arthroplasty for a diagnosis of osteoarthritis or inflammatory arthritis. * Patients have been medically cleared and scheduled for surgery Exclusion Criteria: * Patients with cold-related conditions (cryoglobulinemia, paroxysmal cold hemoglobinuria, cold urticaria, and Raynaud's disease) * Surgery for fracture, infection, or malignancy

Interventions

PROCEDURE

Total knee arthroplasty (TKA)

DEVICE

Cryoablation

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Post-Operative PainTotal Knee Arthroplasty

Locations

NYU Langone Health

New York, New York 10016

United States